Celiac disease: Diagnosis and treatment

Danish Medical Journal

Volumn 62, Issue 4, 2015, Pages 1-13

  Hvas, Christian Lodberg ^b   Jensen, Michael Dam ^b   Reimer, Maria Christina ^b   Riis, Lene Buhl ^b   Rumessen, Jüri Johannes ^b   Skovbjerg, Hanne ^b   Teisner, Ane ^b   Wildt, Signe ^a  

^a KØGE HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CD45 ANTIGEN; GLUTEN; IMMUNOGLOBULIN A; LACTOSE; LARAZOTIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

AMINOTRANSFERASE BLOOD LEVEL; BONE DENSITY; CAPSULE ENDOSCOPY; CELIAC DISEASE; DERMATITIS HERPETIFORMIS; DIARRHEA; DIETARY INTAKE; DISEASE ASSOCIATION; DUODENUM BIOPSY; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; FOLLOW UP; GLUTEN FREE DIET; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE LYMPHOMA; INTESTINE VILLUS ATROPHY; IRON DEFICIENCY ANEMIA; LYMPHOCYTIC INFILTRATION; MALABSORPTION; META ANALYSIS (TOPIC); MINERAL DEFICIENCY; NOTE; OAT; OSTEOPOROSIS; QUALITY OF LIFE; SYSTEMATIC REVIEW (TOPIC); VENOUS THROMBOEMBOLISM; VITAMIN DEFICIENCY; WEIGHT REDUCTION;

EID: 84926052132     PISSN: None     EISSN: 22451919     Source Type: Journal    
DOI: None     Document Type: Note

References (145)

1. Tack GJ, Verbeek WH, Schreurs MW et al. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol 2010;7:204-213.
2. Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357:1731-1743.
3. Rubio-Tapia A, Hill ID, Kelly CP et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013;108:656-676.
4. Mooney PD, Hadjivassiliou M, Sanders DS. Coeliac disease. BMJ 2014;348:g1561.
5. Ludvigsson JF, Leffler DA, Bai JC et al. The Oslo definitions for coeliac disease and related terms. Gut 2013;62:43-52.
6. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006;131:1981-2002.
7. Annibale B, Severi C, Chistolini A et al. Efficacy of gluten-free diet alone on recovery from iron deficiency anemia in adult celiac patients. Am J Gastroenterol 2001;96:132-137.
8. Grisolano SW, Oxentenko AS, Murray JA et al. The usefulness of routine small bowel biopsies in evaluation of iron deficiency anemia. J Clin Gastroenterol 2004;38:756-760.
9. Zamani F, Mohamadnejad M, Shakeri R et al. Gluten sensitive enteropathy in patients with iron deficiency anemia of unknown origin. World J Gastroenterol 2008;14:7381-7385.
10. Alonso-Llamazares J, Gibson LE, Rogers RS, III. Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience. Int J Dermatol 2007;46:910-919.
11. Krishnareddy S, Lewis SK, Green PH. Dermatitis herpetiformis: clinical presentations are independent of manifestations of celiac disease. Am J Clin Dermatol 2014;15:51-56.
12. Fasano A, Berti I, Gerarduzzi T et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163:286-292.
13. Rubio-Tapia A, Van Dyke CT, Lahr BD et al. Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol 2008;6:983-987.
14. Rampertab SD, Pooran N, Brar P et al. Trends in the presentation of celiac disease. Am J Med 2006;119:355-14.
15. Mooney PD, Leeds JS, Libzo N et al. Case-finding for coeliac disease in secondary care: a prospective multicentre UK study. Dig Liver Dis 2014;46:32-35.
16. Mahmud FH, Murray JA, Kudva YC et al. Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc 2005;80:1429-1434.
17. Buysschaert M, Tomasi JP, Hermans MP. Prospective screening for biopsy proven coeliac disease, autoimmunity and malabsorption markers in Belgian subjects with Type 1 diabetes. Diabet Med 2005;22:889-892.
18. Mirzaagha F, Azali SH, Islami F et al. Coeliac disease in autoimmune liver disease: a cross-sectional study and a systematic review. Dig Liver Dis 2010;42:620-623.
19. Sainsbury A, Sanders DS, Ford AC. Meta-analysis: Coeliac disease and hypertransaminasaemia. Aliment Pharmacol Ther 2011;34:33-40.
20. Green PH. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology 2005;128:S74-S78.
21. Hopper AD, Cross SS, Hurlstone DP et al. Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 2007;334:729.
22. Oberhuber G. Histopathology of celiac disease. Biomed Pharmacother 2000;54:368-372.
23. Ravelli A, Villanacci V, Monfredini C et al. How patchy is patchy villous atrophy?: distribution pattern of histological lesions in the duodenum of children with celiac disease. Am J Gastroenterol 2010;105:2103-2110.
24. Hopper AD, Cross SS, Sanders DS. Patchy villous atrophy in adult patients with suspected gluten-sensitive enteropathy: is a multiple duodenal biopsy strategy appropriate? Endoscopy 2008;40:219-224.
25. Pais WP, Duerksen DR, Pettigrew NM et al. How many duodenal biopsy specimens are required to make a diagnosis of celiac disease? Gastrointest Endosc 2008;67:1082-1087.
26. Lebwohl B, Kapel RC, Neugut AI et al. Adherence to biopsy guidelines increases celiac disease diagnosis. Gastrointest Endosc 2011;74:103-109.
27. Gonzalez S, Gupta A, Cheng J et al. Prospective study of the role of duodenal bulb biopsies in the diagnosis of celiac disease. Gastrointest Endosc 2010;72:758-765.
28. Bonamico M, Thanasi E, Mariani P et al. Duodenal bulb biopsies in celiac disease: a multicenter study. J Pediatr Gastroenterol Nutr 2008;47:618-622.
29. Kurien M, Evans KE, Hopper AD et al. Duodenal bulb biopsies for diagnosing adult celiac disease: is there an optimal biopsy site? Gastrointest Endosc 2012;75:1190-1196.
30. Brocchi E, Tomassetti P, Volta U et al. Adult coeliac disease diagnosed by endoscopic biopsies in the duodenal bulb. Eur J Gastroenterol Hepatol 2005;17:1413-1415.
31. Vogelsang H, Hanel S, Steiner B et al. Diagnostic duodenal bulb biopsy in celiac disease. Endoscopy 2001;33:336-340.
32. Bonamico M, Mariani P, Thanasi E et al. Patchy villous atrophy of the duodenum in childhood celiac disease. J Pediatr Gastroenterol Nutr 2004;38:204-207.
33. Evans KE, Aziz I, Cross SS et al. A prospective study of duodenal bulb biopsy in newly diagnosed and established adult celiac disease. Am J Gastroenterol 2011;106:1837-742.
34. Prasad KK, Thapa BR, Nain CK et al. Assessment of the diagnostic value of duodenal bulb histology in patients with celiac disease, using multiple biopsy sites. J Clin Gastroenterol 2009;43:307-311.
35. DeGaetani M, Tennyson CA, Lebwohl B et al. Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol 2013;108:647-653.
36. van der Windt DA, Jellema P, Mulder CJ et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA 2010;303:1738-1746.
37. Lewis NR, Scott BB. Meta-analysis: deamidated gliadin peptide antibody and HLA transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2010;31:73-81.
38. Lewis NR, Scott BB. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and HLA transglutaminase antibody tests). Aliment Pharmacol Ther 2006;24:47-54.
39. Zanini B, Magni A, Caselani F et al. High tissuetransglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease. Dig Liver Dis 2012;44:280-285.
40. Donaldson MR, Book LS, Leiferman KM et al. Strongly positive HLA transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J Clin Gastroenterol 2008;42:256-260.
41. Vermeersch P, Geboes K, Marien G et al. Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease. Clin Chim Acta 2010;411:931-935.
42. Sollid LM, Markussen G, Ek J et al. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989;169:345-350.
43. Ploski R, Ascher H, Sollid LM. HLA genotypes and the increased incidence of coeliac disease in Sweden. Scand J Gastroenterol 1996;31:1092-1097.
44. Karell K, Louka AS, Moodie SJ et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003;64:469-477.
45. Polvi A, Eland C, Koskimies S et al. HLA DQ and DP in Finnish families with celiac disease. Eur J Immunogenet 1996;23:221-234.
46. Hadithi M, von Blomberg BM, Crusius JB et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med 2007;147:294-302.
47. Bao F, Green PH, Bhagat G. An update on celiac disease histopathology and the road ahead. Arch Pathol Lab Med 2012;136:735-745.
48. Lebwohl B, Rubio-Tapia A, Assiri A et al. Diagnosis of celiac disease. Gastrointest Endosc Clin N Am 2012;22:661-677.
49. Leffler D, Schuppan D, Pallav K et al. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut 2013;62:996-1004.
50. Cammarota G, Fedeli P, Gasbarrini A. Emerging technologies in upper gastrointestinal endoscopy and celiac disease. Nat Clin Pract Gastroenterol Hepatol 2009;6:47-56.
51. Rokkas T, Niv Y. The role of video capsule endoscopy in the diagnosis of celiac disease: a meta-analysis. Eur J Gastroenterol Hepatol 2012;24:303-308.
52. Lidums I, Cummins AG, Teo E. The role of capsule endoscopy in suspected celiac disease patients with positive celiac serology. Dig Dis Sci 2011;56:499-505.
53. Kurien M, Evans KE, Aziz I et al. Capsule endoscopy in adult celiac disease: a potential role in equivocal cases of celiac disease? Gastrointest Endosc 2013;77:227-232.
54. Smecuol E, Gonzalez D, Mautalen C et al. Longitudinal study on the effect of treatment on body composition and anthropometry of celiac disease patients. Am J Gastroenterol 1997;92:639-643.
55. Bardella MT, Fredella C, Prampolini L et al. Body composition and dietary intakes in adult celiac disease patients consuming a strict gluten-free diet. Am J Clin Nutr 2000;72:937-939.
56. Johnston SD, Rodgers C, Watson RG. Quality of life in screendetected and typical coeliac disease and the effect of excluding dietary gluten. Eur J Gastroenterol Hepatol 2004;16:1281-1286.
57. Murray JA, Rubio-Tapia A, Van Dyke CT et al. Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol 2008;6:186-193.
58. Haines ML, Anderson RP, Gibson PR. Systematic review: The evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther 2008;28:1042-1066.
59. Haines ML, Anderson RP, Gibson PR. Systematic review: The evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther 2008;28:1042-1066.
60. Sategna-Guidetti C, Grosso SB, Grosso S et al. The effects of 1- year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosed adult coeliac disease patients. Aliment Pharmacol Ther 2000;14:35-43.
61. McFarlane XA, Bhalla AK, Robertson DA. Effect of a gluten free diet on osteopenia in adults with newly diagnosed coeliac disease. Gut 1996;39:180-184.
62. Kemppainen T, Kroger H, Janatuinen E et al. Bone recovery after a gluten-free diet: a 5-year follow-up study. Bone 1999;25:355-360.
63. Khashan AS, Henriksen TB, Mortensen PB et al. The impact of maternal celiac disease on birthweight and preterm birth: a Danish population-based cohort study. Hum Reprod 2010;25:528-534.
64. Ludvigsson JF, Montgomery SM, Ekbom A. Celiac disease and risk of adverse fetal outcome: a population-based cohort study. Gastroenterology 2005;129:454-463.
65. Gibert A, Kruizinga AG, Neuhold S et al. Might gluten traces in wheat substitutes pose a risk in patients with celiac disease? A population-based probabilistic approach to risk estimation. Am J Clin Nutr 2013;97:109-116.
66. Akobeng AK, Thomas AG. Systematic review: tolerable amount of gluten for people with coeliac disease. Aliment Pharmacol Ther 2008;27:1044-1052.
67. Kemppainen TA, Heikkinen MT, Ristikankare MK et al. Nutrient intakes during diets including unkilned and large amounts of oats in celiac disease. Eur J Clin Nutr 2010;64:62-67.
68. Storsrud S, Olsson M, Arvidsson LR et al. Adult coeliac patients do tolerate large amounts of oats. Eur J Clin Nutr 2003;57:163-169.
69. Pulido OM, Gillespie Z, Zarkadas M et al. Introduction of oats in the diet of individuals with celiac disease: a systematic review. Adv Food Nutr Res 2009;57:235-285.
70. Fric P, Gabrovska D, Nevoral J. Celiac disease, gluten-free diet, and oats. Nutr Rev 2011;69:107-115.
71. Cooper SE, Kennedy NP, Mohamed BM et al. Immunological indicators of coeliac disease activity are not altered by long-term oats challenge. Clin Exp Immunol 2013;171:313-318.
72. Thompson T. Gluten contamination of commercial oat products in the United States. N Engl J Med 2004;351:2021-2022.
73. Dostalek P, Hochel I, Mendez E et al. Immunochemical determination of gluten in malts and beers. Food Addit Contam 2006;23:1074-1078.
74. Tanner GJ, Colgrave ML, Blundell MJ et al. Measuring hordein (gluten) in beer--a comparison of ELISA and mass spectrometry. PLoS One 2013;8:e56452.
75. Saibeni S, Lecchi A, Meucci G et al. Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics. Clin Gastroenterol Hepatol 2005;3:574-580.
76. Kupper C. Dietary guidelines and implementation for celiac disease. Gastroenterology 2005;128:S121-S127.
77. Storsrud S, Hulthen LR, Lenner RA. Beneficial effects of oats in the gluten-free diet of adults with special reference to nutrient status, symptoms and subjective experiences. Br J Nutr 2003;90:101-107.
78. Hallert C, Svensson M, Tholstrup J et al. Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet. Aliment Pharmacol Ther 2009;29:811-816.
79. Ciacci C, Maiuri L, Russo I et al. Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: an in vivo/in vitro pilot study. Clin Exp Pharmacol Physiol 2009;36:1170-1176.
80. Latorre M, Green PH. The role of corticosteroids in celiac disease. Dig Dis Sci 2012;57:3039-3041.
81. Shalimar, Das P, Sreenivas V et al. Effect of addition of short course of prednisolone to gluten-free diet on mucosal epithelial cell regeneration and apoptosis in celiac disease: a pilot randomized controlled trial. Dig Dis Sci 2012;57:3116-3125.
82. Leffler DA, Kelly CP, Abdallah HZ et al. A randomized, doubleblind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol 2012;107:1554-1562.
83. Kelly CP, Green PH, Murray JA et al. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study. Aliment Pharmacol Ther 2013;37:252-262.
84. Olmos M, Antelo M, Vazquez H et al. Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis 2008;40:46-53.
85. Ludvigsson JF, Michaelsson K, Ekbom A et al. Coeliac disease and the risk of fractures - a general population-based cohort study. Aliment Pharmacol Ther 2007;25:273-285.
86. Fouda MA, Khan AA, Sultan MS et al. Evaluation and management of skeletal health in celiac disease: position statement. Can J Gastroenterol 2012;26:819-829.
87. Moreno ML, Vazquez H, Mazure R et al. Stratification of bone fracture risk in patients with celiac disease. Clin Gastroenterol Hepatol 2004;2:127-134.
88. Lewis NR, Scott BB. Should patients with coeliac disease have their bone mineral density measured? Eur J Gastroenterol Hepatol 2005;17:1065-1070.
89. Koop I, Ilchmann R, Izzi L et al. Detection of autoantibodies against HLA transglutaminase in patients with celiac disease and dermatitis herpetiformis. Am J Gastroenterol 2000;95:2009-2014.
90. Nachman F, Sugai E, Vazquez H et al. Serological tests for celiac disease as indicators of long-term compliance with the gluten-free diet. Eur J Gastroenterol Hepatol 2011;23:473-480.
91. Hall NJ, Rubin G, Charnock A. Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther 2009;30:315-330.
92. Tursi A, Elisei W, Giorgetti GM et al. Complications in celiac disease under gluten-free diet. Dig Dis Sci 2009;54:2175-2182.
93. Leffler DA, Edwards-George J, Dennis M et al. Factors that influence adherence to a gluten-free diet in adults with celiac disease. Dig Dis Sci 2008;53:1573-1581.
94. Nachman F, del Campo MP, Gonzalez A et al. Long-term deterioration of quality of life in adult patients with celiac disease is associated with treatment noncompliance. Dig Liver Dis 2010;42:685-691.
95. Rubio-Tapia A, Murray JA. Classification and management of refractory coeliac disease. Gut 2010;59:547-557.
96. Jacobsson LR, Friedrichsen M, Goransson A et al. Impact of an active patient education program on gastrointestinal symptoms in women with celiac disease following a gluten-free diet: a randomized controlled trial. Gastroenterol Nurs 2012;35:200-206.
97. Sainsbury K, Mullan B, Sharpe L. A randomized controlled trial of an online intervention to improve gluten-free diet adherence in celiac disease. Am J Gastroenterol 2013;108:811-817.
98. Errichiello S, Esposito O, Di MR et al. Celiac disease: predictors of compliance with a gluten-free diet in adolescents and young adults. J Pediatr Gastroenterol Nutr 2010;50:54-60.
99. Sugai E, Nachman F, Vaquez H et al. Dynamics of celiac disease- specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment. Dig Liver Dis 2010;42:352-358.
100. Midhagen G, Aberg AK, Olcen P et al. Antibody levels in adult patients with coeliac disease during gluten-free diet: a rapid initial decrease of clinical importance. J Intern Med 2004;256:519-524.
101. Martin-Pagola A, Ortiz-Paranza L, Bilbao JR et al. Two-year follow-up of anti-transglutaminase autoantibodies among celiac children on gluten-free diet: comparison of IgG and IgA. Autoimmunity 2007;40:117-121.
102. Kaukinen K, Sulkanen S, Maki M et al. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol 2002;14:311-315.
103. Lanzini A, Lanzarotto F, Villanacci V et al. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther 2009;29:1299-1308.
104. Rubio-Tapia A, Rahim MW, See JA et al. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol 2010;105:1412-1420.
105. Roshan B, Leffler DA, Jamma S et al. The incidence and clinical spectrum of refractory celiac disease in a north american referral center. Am J Gastroenterol 2011;106:923-928.
106. Ilus T, Kaukinen K, Virta LJ et al. Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease. Aliment Pharmacol Ther 2014;39:418-425.
107. Cellier C, Delabesse E, Helmer C et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000;356:203-208.
108. Malamut G, Afchain P, Verkarre V et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2009;136:81-90.
109. Barret M, Malamut G, Rahmi G et al. Diagnostic yield of capsule endoscopy in refractory celiac disease. Am J Gastroenterol 2012;107:1546-1553.
110. Daum S, Wahnschaffe U, Glasenapp R et al. Capsule endoscopy in refractory celiac disease. Endoscopy 2007;39:455-458.
111. Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 2005;128:S79-S86.
112. Gao Y, Kristinsson SY, Goldin LR et al. Increased risk for non- Hodgkin lymphoma in individuals with celiac disease and a potential familial association. Gastroenterology 2009;136:91-98.
113. Elfstrom P, Granath F, Ekstrom SK et al. Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst 2011;103:436-444.
114. Grainge MJ, West J, Solaymani-Dodaran M et al. The longterm risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther 2012;35:730-739.
115. Tio M, Cox MR, Eslick GD. Meta-analysis: coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy. Aliment Pharmacol Ther 2012;35:540-551.
116. Verbeek WH, Van De Water JM, Al-Toma A et al. Incidence of enteropathy--associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands. Scand J Gastroenterol 2008;43:1322-1328.
117. Al-Toma A, Verbeek WH, Hadithi M et al. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 2007;56:1373-1378.
118. Holmes GK, Prior P, Lane MR et al. Malignancy in coeliac disease--effect of a gluten free diet. Gut 1989;30:333-338.
119. Olen O, Askling J, Ludvigsson JF et al. Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype. Dig Liver Dis 2011;43:862-868.
120. Lebwohl B, Granath F, Ekbom A et al. Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population- based cohort study. Ann Intern Med 2013;159:169-175.
121. Hadithi M, Mallant M, Oudejans J et al. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J Nucl Med 2006;47:1622-1627.
122. Ludvigsson JF. Mortality and malignancy in celiac disease. Gastrointest Endosc Clin N Am 2012;22:705-722.
123. West J, Logan RF, Smith CJ et al. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ 2004;329:716-719.
124. Green PH, Fleischauer AT, Bhagat G et al. Risk of malignancy in patients with celiac disease. Am J Med 2003;115:191-195.
125. Askling J, Linet M, Gridley G et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 2002;123:1428-1435.
126. Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 2004;20:769-775.
127. Elfstrom P, Granath F, Ye W et al. Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease. Clin Gastroenterol Hepatol 2012;10:30-36.
128. Ludvigsson JF, West J, Ekbom A et al. Reduced risk of breast, endometrial and ovarian cancer in women with celiac disease. Int J Cancer 2012;131:E244-E250.
129. Viljamaa M, Kaukinen K, Pukkala E et al. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis 2006;38:374-380.
130. Corrao G, Corazza GR, Bagnardi V et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001;358:356-361.
131. Peters U, Askling J, Gridley G et al. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003;163:1566-1572.
132. West J, Logan RF, Smith CJ et al. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ 2004;329:716-719.
133. Ludvigsson JF, Montgomery SM, Ekbom A et al. Smallintestinal histopathology and mortality risk in celiac disease. JAMA 2009;302:1171-1178.
134. Grainge MJ, West J, Card TR et al. Causes of death in people with celiac disease spanning the pre- and post-serology era: a population-based cohort study from Derby, UK. Am J Gastroenterol 2011;106:933-939.
135. Wei L, Spiers E, Reynolds N et al. The association between coeliac disease and cardiovascular disease. Aliment Pharmacol Ther 2008;27:514-519.
136. Ludvigsson JF, James S, Askling J et al. Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease. Circulation 2011;123:483-490.
137. West J, Logan RF, Card TR et al. Risk of vascular disease in adults with diagnosed coeliac disease: a population-based study. Aliment Pharmacol Ther 2004;20:73-79.
138. Ludvigsson JF, Olen O, Bell M et al. Coeliac disease and risk of sepsis. Gut 2008;57:1074-1080.
139. Halfdanarson TR, Litzow MR, Murray JA. Hematologic manifestations of celiac disease. Blood 2007;109:412-421.
140. Baydoun A, Maakaron JE, Halawi H et al. Hematological manifestations of celiac disease. Scand J Gastroenterol 2012;47:1401-1411.
141. Miehsler W, Reinisch W, Valic E et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004;53:542-548.
142. Ludvigsson JF, Welander A, Lassila R et al. Risk of thromboembolism in 14,000 individuals with coeliac disease. Br J Haematol 2007;139:121-127.
143. Ramagopalan SV, Wotton CJ, Handel AE et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 2011;9:1.
144. Johannesdottir SA, Erichsen R, Horvath-Puho E et al. Coeliac disease and risk of venous thromboembolism: a nationwide population- based case-control study. Br J Haematol 2012;157:499-501.
145. Biesiekierski JR, Peters SL, Newnham ED et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, shortchain carbohydrates. Gastroenterology 2013;145:320-328.